0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Commentary |

Cocaine Reward and Dopamine Receptors:  Love at First Site

George F. Koob, PhD
Arch Gen Psychiatry. 1999;56(12):1107-1108. doi:10.1001/archpsyc.56.12.1107.
Text Size: A A A
Published online

Extract

A NEW clinical study by Romach et al1 reports that the D1 selective antagonist ecopipam (SCH 39166) blocks the subjective effects of intravenous cocaine in patients with a diagnosis of cocaine dependence. Using a randomized double-blind placebo-controlled design, ecopipam administered to humans 2 hours prior to an intravenous injection of 30 mg of cocaine dose-dependently blocked the subjective effects of cocaine. These doses of ecopipam did not block the effects of cocaine on heart rate or produce any other untoward effects. These are very exciting observations for 2 reasons. First, the results suggest that a dopamine-selective D1 dopaminergic antagonist is effective in humans in blocking the psychotropic effects of cocaine and second, these observations begin to validate a wealth of preclinical data suggesting powerful cocaine antagonistic effects of dopamine D1 antagonists.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 9

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();